From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Dermatology>
  4. Summary and Comment

Pityriasis Rosea in Pregnancy

This common illness can have deleterious effects when it occurs early in pregnancy.

Pityriasis rosea (PR), an acute illness marked by a papulosquamous eruption, mainly affects children and young adults. Some studies implicate a viral cause, especially a primary or reactivated infection with human herpes viruses (HHVs) 6 and 7, but the evidence is inconclusive. Although the disease is self-limited, usually resolving after 6 to 8 weeks without any apparent residua, one concern is its effects in pregnancy. Investigators in Italy examined 38 women who developed PR during pregnancy.

Of these women, five miscarried (13%), but the miscarriage rate was 62% in those who developed PR in the first 15 weeks of pregnancy. Hypotonia and weak motion were common in the infants of women who developed PR between 16 and 20 weeks’ gestation; only 33% of these pregnancies produced healthy infants at delivery. Nine women (24%) had premature deliveries. However, all premature neonates survived and were healthy at the time of the report.

PR was exceptionally severe in all the mothers who miscarried. These women had longer courses, more-widespread skin lesions, and more frequent than usual systemic complaints, such as headache, insomnia, anorexia, and fatigue. Detailed study of one woman who miscarried indicated active infection with HHV-6 in both the mother and the fetus.

Comment: This report demonstrates a high risk for fetal loss and for neonatal weakness and hypotonia in pregnancies affected by PR during the early weeks of gestation. Clinicians should alert women who develop PR in pregnancy about the potential risks of this presumed viral infection, although there is no known effective intervention to prevent these complications. Nor is there a clear way to avoid this illness. The detailed study of the miscarried fetus suggested reactivation of HHV-6, rather than primary infection, based on observation in the mother of specific serum IgG antibody but no IgM antibody.

Jan V. Hirschmann, MD

Published in Journal Watch Dermatology May 30, 2008

Citation(s):

Drago F et al. Pregnancy outcome in patients with pityriasis rosea. J Am Acad Dermatol 2008 May; 58:S78.

Reader Remarks:

Review and add to remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2008. Massachusetts Medical Society. All rights reserved.